TY - JOUR
T1 - 電子的手法によるインフォームド・コンセントを受ける手続きに関する実態調査:臨床研究コーディネーター等を対象とした Web アンケート調査
AU - Terada, Mari
AU - Sato, Yayoi
AU - Osawa, Tomoko
AU - Iijima, Yoshihiko
AU - Goto, Miho
AU - Tamaura, Akemi
N1 - Publisher Copyright:
Copyright:©2023 the Japanese Society of Clinical Pharmacology and Therapeutics(JSCPT)
PY - 2023
Y1 - 2023
N2 - Clinical trials have become increasingly electronic and digitalized, and electronic informed consent has begun to gain importance. In order to picture the current situation of eConsent in Japanese medical institutions, we asked research assistants, including CRCs, to answer a questionnaire survey. Responses were obtained from 1403 persons. The experience with eConsent was low; 128(9.1%)had used in informing process and 71(5.1%)in consent process. Of those with eConsent experience, 94(73.4%)had experience in in-person only study and 13 (10.9%)in remote only study. In cases where eConsent was considered but abandoned, respondents reported that medical institution did not have sufficient SOP, tablet devices, and/or internet network. Many also expressed concern about the ability of elderly patients to use electronic methods. The importance of eConsent is expected to increase, as clinical trials are anticipated to become diverse, including those requiring remote access, non-contact manner, or virtual conduction. Accordingly, we should consider an appropriate eConsent that is beneficial to all the stakeholders ‒ the sponsor, medical institution, and the subject ‒ and it should become a natural option in the future, in situations where eConsent is necessary.
AB - Clinical trials have become increasingly electronic and digitalized, and electronic informed consent has begun to gain importance. In order to picture the current situation of eConsent in Japanese medical institutions, we asked research assistants, including CRCs, to answer a questionnaire survey. Responses were obtained from 1403 persons. The experience with eConsent was low; 128(9.1%)had used in informing process and 71(5.1%)in consent process. Of those with eConsent experience, 94(73.4%)had experience in in-person only study and 13 (10.9%)in remote only study. In cases where eConsent was considered but abandoned, respondents reported that medical institution did not have sufficient SOP, tablet devices, and/or internet network. Many also expressed concern about the ability of elderly patients to use electronic methods. The importance of eConsent is expected to increase, as clinical trials are anticipated to become diverse, including those requiring remote access, non-contact manner, or virtual conduction. Accordingly, we should consider an appropriate eConsent that is beneficial to all the stakeholders ‒ the sponsor, medical institution, and the subject ‒ and it should become a natural option in the future, in situations where eConsent is necessary.
UR - http://www.scopus.com/inward/record.url?scp=85152209113&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152209113&partnerID=8YFLogxK
U2 - 10.3999/jscpt.54.1_19
DO - 10.3999/jscpt.54.1_19
M3 - 学術論文
AN - SCOPUS:85152209113
SN - 0388-1601
VL - 54
SP - 19
EP - 28
JO - Japanese Journal of Clinical Pharmacology and Therapeutics
JF - Japanese Journal of Clinical Pharmacology and Therapeutics
IS - 1
ER -